TAKIS SRL -  

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000

Ranking timeline:

Project Participation Performance(2019-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 4
As coordinator: 0
As participant: 3
Sole participant: 1
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 0 5.845.857 284.125 1
2020 0 11.773.000 225.063 1
2019 50.000 3.915.903 311.500 1 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
COMMISSARIAT A L'ENERGIE ATOMIQUE2
ALVO SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA SPOLKA KOMANDYTOWA1
ASPHALION SL1
ASTELLAS PHARMA EUROPE BV1
BAYER1
CELLCOMB AB1
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE1
CENTRO DE NEUROCIENCIAS E BIOLOGIACELULAR ASSOCIACAO1
CHARLES UNIVERSITY PRAGUE1
CONSORZIO INTERUNIVERSITARIO NAZIONALE PER LA SCIENZA E TECNOLOGIA DEI MATERIALI1
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH1
EOTVOS LORAND TUDOMANYEGYETEM1
EXIRIS1
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V1
GENETHON1
GENOSAFE SAS1
HEIDELBERG PHARMA RESEARCH1
HELIOENERGIA SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA1
IDENER RESEARCH & DEVELOPMENT AGRUPACION DE INTERES ECONOMICO1
INSTITUT DU CERVEAU ET DE LA MOELLE EPINIERE1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE1
INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA1
JANSSEN PHARMACEUTICA NV1
LONZA1
LUND UNIVERSITY1
LYSOGENE1
MEDIZINISCHE HOCHSCHULE HANNOVER1
MILLIDYNE OY1
MIMETAS BV1
NOVARTIS PHARMA1
NOVO NORDISK1
ORSZAGOS ONKOLOGIAI INTEZET1
PFIZER LIMITED1
PHARMACOIDEA FEJLESZTO ES SZOLGALTATO KFT1
PHILOCHEM1
PROTEC SURFACE TECHNOLOGIES1
RINA CONSULTING CENTRO SVILUPPO MATERIALI1
SANOFIAVENTIS1
SIEC BADAWCZA LUKASIEWICZ INSTYTUT METALI NIEZELAZNYCH1
SPARK THERAPEUTICS INC1
SUDMETALL BESCHLAGE1
SYNVACCINE1
TAKEDA PHARMACEUTICALS INTERNATIONAL1
TECHNISCHE UNIVERSITAET DARMSTADT1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD1
THE ROSALIND FRANKLIN INSTITUTE1
THE UNIVERSITY OF LIVERPOOL1
THE UNIVERSITY OF SHEFFIELD1
UNIVERSITA DEGLI STUDI DELL'INSUBRIA1
UNIVERSITA DEGLI STUDI DI MILANO1
UNIVERSITAET BIELEFELD1
UNIVERSITAET ZU KOELN1
UNIVERSITAETSKLINIKUM HEIDELBERG1
UNIVERSITY COLLEGE LONDON1
UNIVERSITY OF CAMBRIDGE1
UNIVERSITY OF EASTERN FINLAND1
UNIVERSITY OF HELSINKI1
UNIVERSITY OF NEWCASTLE UPON TYNE1
VISCOFAN1
VTT TECHNICAL RESEARCH CENTRE OF FINLAND1

Constancy:

Total number of partners: 61
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 61
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2022-06-01DEVELOPMENT OF ANTIMICROBIAL, ANTIVIRAL, AND ANTIFUNGAL NANOCOATINGS FOR EVERYDAY SURFACES MIRIAparticipant5.845.85715
2020-11-01Accelerating Research & Development for Advanced Therapies ARDATparticipant11.773.00034
2019-11-01Small-Molecule Drug Conjugates for Targeted Delivery in Tumor Therapy Magicbullet Reloadedparticipant3.915.90315
2019-08-01Personalized Cancer Immunotherapy through DNA-EP vaccines TK-NEOcoordinator50.0001